Arg22

Site Information
DRICEGIrPQIMNGP SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 27270090

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 )
Relevant cell line - cell type - tissue:	brain ( 1 , 2 , 3 , 6 , 7 , 8 , 9 ) , embryo ( 1 , 4 , 5 , 10 , 11 , 12 , 13 )

References
1	Guo A, et al. (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13, 372-87 24129315 Curated Info
2	Mulhern D (2012) CST Curation Set: 15837; Year: 2012; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
3	Mulhern D (2012) CST Curation Set: 15838; Year: 2012; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
4	Mulhern D (2012) CST Curation Set: 15845; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
5	Mulhern D (2012) CST Curation Set: 15846; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
6	Guo A (2012) CST Curation Set: 14306; Year: 2012; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
7	Guo A (2012) CST Curation Set: 14307; Year: 2012; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
8	Guo A (2012) CST Curation Set: 14310; Year: 2012; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
9	Guo A (2012) CST Curation Set: 14311; Year: 2012; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
10	Guo A (2012) CST Curation Set: 14308; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
11	Guo A (2012) CST Curation Set: 14309; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
12	Guo A (2012) CST Curation Set: 14312; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info
13	Guo A (2012) CST Curation Set: 14313; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR Curated Info